Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Self-citation
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,485
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,328
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,457
An Enzyme from Bacteria able to Destroy Penicillin
Abraham, E. P., & Chain, E. B. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,335
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,322
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,149
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Pérez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,138
Self-citation
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,078
A standard numbering scheme for the class A β -lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J., Ghuysen, J., Joris, B., Forsman, M., Lévesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,076
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 914
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
Knothe, H., Shah, P., Krčméry, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 911
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 821
The New β-Lactamases
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 806
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
Ciprofloxacin
Campoli-Richards, D. M., Monk, J. P., Price, A. H., Benfield, P., Todd, P. A., & Ward, A. (1988) · Drugs · doi:10.2165/00003495-198835040-00003 · Cited by 750
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 740
A relationship between protein stability and protein function.
Shoichet, B. K., Baase, W. A., Kuroki, R., & Matthews, B. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.452 · Cited by 712
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras‐Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 690
Evaluation of Enzyme Inhibitors in Drug Discovery
Copeland, R. A. (2013) · Wiley eBooks · doi:10.1002/9781118540398 · Cited by 689
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 686
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 660
Multimodular Penicillin-Binding Proteins: An Enigmatic Family of Orthologs and Paralogs
Goffin, C., & Ghuysen, J. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1079-1093.1998 · Cited by 631
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 612
Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action
Edwards, D. I. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.1.9 · Cited by 605
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
Datta, N., & Kontomichalou, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 571
Resistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 542
Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution
Strynadka, N. C. J., Adachi, H., Jensen, S. E., Johns, K. L., Sielecki, A. R., Betzel, C., Sutoh, K., & James, M. N. G. (1992) · Nature · doi:10.1038/359700a0 · Cited by 525
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Hugonnet, J., Tremblay, L. W., Boshoff, H. I., Barry, C. E., & Blanchard, J. S. (2009) · Science · doi:10.1126/science.1167498 · Cited by 506
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
OXA-type carbapenemases
Walther‐Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 497
Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York City
Bradford, P. A., Bratu, S., Urban, C. M., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. M. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Self-citation
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
Doumith, M., Ellington, M. J., Livermore, D. M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp029 · Cited by 449
Kinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases
Massova, I., & Mobashery, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.1 · Cited by 422
Standard Numbering Scheme for Class B β-Lactamases
Galleni, M., Lamotte‐Brasseur, J., Rossolini, G. M., Spencer, J., Dideberg, O., Frère, J., & The Metallo-β-Lactamase Working Group (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.660-663.2001 · Cited by 414
CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization
English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., & Barth, W. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.414 · Cited by 405
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 393
Metallo-β-lactamases: Novel Weaponry for Antibiotic Resistance in Bacteria
Crowder, M. W., SPENCER, J. M., & Vila, A. J. (2006) · Accounts of Chemical Research · doi:10.1021/ar0400241 · Cited by 385
Carbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 362
Crystal structure of Escherichia coli TEM1 β‐lactamase at 1.8 Å resolution
Jelsch, C., Mourey, L., Masson, J., & Samama, J. (1993) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340160406 · Cited by 361
Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å Resolution
Herzberg, O., & Moult, J. (1987) · Science · doi:10.1126/science.3107125 · Cited by 351
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K., Lauwereys, M., Galleni, M., Matagne, A., Frère, J., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 348
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. (1988) · PubMed · Cited by 341
Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin
Imada, A., Kitano, K., Kintaka, K., Muroi, M., & Asai, M. (1981) · Nature · doi:10.1038/289590a0 · Cited by 336
Cytosolic Intermediates for Cell Wall Biosynthesis and Degradation Control Inducible β-Lactam Resistance in Gram-Negative Bacteria
Jacobs‐Wagner, C., Frère, J., & Normark, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81928-5 · Cited by 334
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria
SYKES, R. B., BONNER, D. P., Bush, K., & Georgopapadakou, N. H. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.1.85 · Cited by 314
Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center
Rice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.118 · Cited by 313
Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure
Knox, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2593 · Cited by 312
Crystal Structure of the IMP-1 Metallo β-Lactamase from Pseudomonas aeruginosa and Its Complex with a Mercaptocarboxylate Inhibitor: Binding Determinants of a Potent, Broad-Spectrum Inhibitor,
Concha, N. O., Janson, C. A., Rowling, P., Pearson, S. C., Cheever, C. A., Clarke, B. P., Lewis, C. J., Galleni, M., Frère, J., Payne, D. J., et al. (2000) · Biochemistry · doi:10.1021/bi992569m · Cited by 309
Manipulation of a Hospital Antimicrobial Formulary to Control an Outbreak of Vancomycin-Resistant Enterococci
Quale, J. M., Landman, D., Saurina, G., Atwood, E., Ditore, V., & Patel, K. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1020 · Cited by 306
Expansion of the zinc metallo‐hydrolase family of the β‐lactamase fold
Daiyasu, H., Osaka, K., Ishino, Y., & Toh, H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02686-2 · Cited by 304
Monocyclic β-lactam antibiotics produced by bacteria
SYKES, R. B., CIMARUSTI, C. M., BONNER, D. P., Bush, K., FLOYD, D. M., Georgopapadakou, N. H., Koster, W. H., Liu, W. C., Parker, W. L., Principe, P. A., et al. (1981) · Nature · doi:10.1038/291489a0 · Cited by 304
The continuing challenge of ESBLs
Pérez, F., Endimiani, A., Hujer, K. M., & Bonomo, R. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.003 · Cited by 304
Self-citation
Refined crystal structure of β-lactamase from Citrobacter freundiiindicates a mechanism for β-lactam hydrolysis
Oefner, C., D'Arcy, A., Daly, J. J., Gubernator, K., Charnas, R. L., Heinze, I., Hubschwerlen, C., & Winkler, F. K. (1990) · Nature · doi:10.1038/343284a0 · Cited by 300
Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 289
Update of the Standard Numbering Scheme for Class B β-Lactamases
Garau, G., Garcia-Saez, I., Bebrone, C., Anne, C., Mercuri, P. S., Galleni, M., Frère, J., & Dideberg, O. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2347-2349.2004 · Cited by 288
Acquisition of Resistance to Carbapenems in Multidrug-Resistant Clinical Strains of Acinetobacter baumannii : Natural Insertional Inactivation of a Gene Encoding a Member of a Novel Family of β-Barrel Outer Membrane Proteins
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 285
Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumannii
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 283
Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome
Tumbarello, M., Spanu, T., Sanguinetti, M., Citton, R., Montuori, E. A., Leone, F., Fadda, G., & Cauda, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.498-504.2006 · Cited by 283
Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin‐resistant clinical isolates of Streptococcus pneumoniae
Laible, G., Spratt, B. G., & Hakenbeck, R. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00821.x · Cited by 280
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance
Li, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., LEE, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 277
Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge
Rodríguez‐Baño, J., Navarro, M. D., Romero, L., Muniain, M. A., de Cueto, M., Ríos, M., Hernandez, J. R., & Pascual, Á. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 276
Metallo-β-lactamase: structure and mechanism
Wang, Z., Fast, W. L., Valentine, A. M., & Benkovic, S. J. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00017-4 · Cited by 275
Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 270
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant
Angus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M., & Hancock, R. E. W. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.2.299 · Cited by 262
Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Chaibi, E. B., Sirot, D., Paul, G., & Labia, R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.447 · Cited by 256
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase
TONEY, J. H., Fitzgerald, P. M. D., Grover-Sharma, N., Olson, S. H., May, W. J., Sundelof, J. G., Vanderwall, D. E., Cleary, K. A., Grant, S. K., Wu, J. K., et al. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90632-9 · Cited by 243
Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases
Golemi, D., Maveyraud, L., Vakulenko, S. B., Samama, J., & Mobashery, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241442898 · Cited by 242
Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
Orencia, M. C., Yoon, J. S., Ness, J. E., Stemmer, W. P. C., & Stevens, R. C. (2001) · Nature Structural Biology · doi:10.1038/84981 · Cited by 239
What's new in antibiotic resistance? Focus on beta-lactamases
BABIC, M., Hujer, A. M., & Bonomo, R. A. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.005 · Cited by 239
Self-citation
Clavulanic Acid, a Novel Inhibitor of β-Lactamases
Neu, H. C., & Fu, K. P. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.5.650 · Cited by 239
Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced by Escherichia coli
Laraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., Pauw, E. D., Amicosante, G., Frère, J., & Galleni, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.902 · Cited by 237
A Metallo-β-lactamase Enzyme in Action: Crystal Structures of the Monozinc Carbapenemase CphA and its Complex with Biapenem
Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J., & Dideberg, O. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.070 · Cited by 232
Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases
Jacoby, G. A., & Carreras, I. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.858 · Cited by 227
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae
Rasmussen, B. A., Bush, K., Keeney, D. R., Yang, Y., Hare, R. S., O'Gara, C. J., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Endimiani, A., Hujer, A. M., Pérez, F., Bethel, C. R., Hujer, K. M., Kroeger, J. S., Oethinger, M. D., Paterson, D. L., Adams, M. D., Jacobs, M. R., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn547 · Cited by 216
Self-citation
Minor extended-spectrum β-lactamases
Naas, T., Poirel, L., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01861.x · Cited by 215
An Ultrahigh Resolution Structure of TEM-1 β-Lactamase Suggests a Role for Glu166 as the General Base in Acylation
Minasov, G., Wang, X., & Shoichet, B. K. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0259640 · Cited by 214
Beta-lactamase inhibitors from laboratory to clinic
Bush, K. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.109 · Cited by 211
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods
Livermore, D. M. (1987) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013107 · Cited by 211
Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: natural events and laboratory simulation
Bowler, L. D., Zhang, Q. Y., Riou, J. Y., & Spratt, B. G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.2.333-337.1994 · Cited by 206
Metallo‐β‐Lactamases: A Class Apart
Bush, K. (1998) · Clinical Infectious Diseases · doi:10.1086/514922 · Cited by 206
Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase
TONEY, J. H., Hammond, G. G., Fitzgerald, P. M. D., Sharma, N., Balkovec, J. M., Rouen, G. P., Olson, S. H., Hammond, M. L., Greenlee, M. L., & Gao, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104742200 · Cited by 205
Role of β-Lactamases and Porins in Resistance to Ertapenem and Other β-Lactams in Klebsiella pneumoniae
Jacoby, G. A., Mills, D. M., & Chow, N. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3203-3206.2004 · Cited by 205
Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid
Fisher, J. F., Charnas, R. L., & Knowles, J. R. (1978) · Biochemistry · doi:10.1021/bi00604a024 · Cited by 204
Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 203
Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae.
Dowson, C. G., Hutchison, A., Woodford, N., Johnson, A. P., George, R. C., & Spratt, B. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5858 · Cited by 202
Beta-lactamase-mediated resistance and opportunities for its control
Livermore, D. M. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_4.25 · Cited by 194
Regulation of Inducible AmpC Beta-Lactamase Expression Among Enterobacteriaceae
Hanson, N. D., & Sanders, C. C. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112191507 · Cited by 194
A new plasmidic cefotaximase from patients infected withSalmonella typhimurium
Bauernfeind, A., Holley, M., Jungwirth, R., Mangold, P., Röhnisch, T., Schweighart, S., Wilhelm, R., Casellas, J. M., & Goldberg, M. (1992) · Infection · doi:10.1007/bf01704610 · Cited by 192
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients
Naumovski, L., Quinn, J. P., Miyashiro, D. K., Patel, M., Bush, K., Singer, S. B., Graves, D., Palzkill, T. G., & Arvin, A. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1991 · Cited by 189
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Doménech‐Sánchez, A., Albertí, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor
Bonnefoy, A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh358 · Cited by 185
OXA-type beta-lactamases.
Naas, T., & Nordmann, P. (1999) · PubMed · Cited by 183
Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase
Papp‐Wallace, K. M., Bethel, C. R., Distler, A. M., Kasuboski, C., Taracila, M. A., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00693-09 · Cited by 180
Self-citation
In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
Stachyra, T., Levasseur, P., Péchereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., & BLACK, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp197 · Cited by 180
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review
Falagas, M. E., Valkimadi, P.-E., Huang, Y., Matthaiou, D. K., & Hsueh, P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn301 · Cited by 179
On the Mechanism of the Metallo-β-lactamase from Bacteroides fragilis
Wang, Z., Fast, W., & Benkovic, S. J. (1999) · Biochemistry · doi:10.1021/bi990356r · Cited by 177
Zn(II) Dependence of the Aeromonas hydrophila AE036 Metallo-β-lactamase Activity and Stability
Hernandez-Valladares, M., Felici, A., Weber, G., Adolph, H. W., Zeppezauer, M. M., Rossolini, G. M., Amicosante, G., Frère, J., & Galleni, M. (1997) · Biochemistry · doi:10.1021/bi971056h · Cited by 176
Mechanism of acyl transfer by the class A serine β-lactamase of Streptomyces albus G
Lamotte‐Brasseur, J., Dive, G., Dideberg, O., Charlier, P., Frère, J., & Ghuysen, J. (1991) · Biochemical Journal · doi:10.1042/bj2790213 · Cited by 173
β‐Lactamase of Bacillus licheniformis 749/C at 2 Å resolution
Moews, P. C., Knox, J. R., Dideberg, O., Charlier, P., & Frère, J. (1990) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340070205 · Cited by 173
Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa
Li, X.-Z., Zhang, L., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.433 · Cited by 173
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases
Payne, D. J., Cramp, R., Winstanley, D. J., & KNOWLES, D. J. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.767 · Cited by 171
Plasmid-linked ampicillin resistance in haempohilus influenza type b
Elwell, L. P., Graaff, J., Seibert, D., & Falkow, S. (1975) · Infection and Immunity · doi:10.1128/iai.12.2.404-410.1975 · Cited by 165
Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 164
Effect of Sulbactam on Infections Caused by Imipenem-ResistantAcinetobacter calcoaceticusBiotypeanitratus
Urban, C. M., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Reduction in the Incidence of Methicillin‐Resistant Staphylococcus aureus and Ceftazidime‐Resistant Klebsiella pneumoniae Following Changes in a Hospital Antibiotic Formulary
Landman, D., Chockalingam, M., & Quale, J. M. (1999) · Clinical Infectious Diseases · doi:10.1086/514743 · Cited by 162
Influence of Mutations in the mexR Repressor Gene on Expression of the MexA-MexB-OprM Multidrug Efflux System of Pseudomonas aeruginosa
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 162
Crystal structure of the class D beta-lactamase OXA-10.
Strynadka, N. C. J., Paetzel, M., Danel, F., de Castro, L., Mosimann, S. C., & Page, M. G. P. (2000) · Nature Structural Biology · doi:10.1038/79688 · Cited by 161
Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas-Chanoine, M.-H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Ab Initio QM/MM Study of Class A β-Lactamase Acylation: Dual Participation of Glu166 and Lys73 in a Concerted Base Promotion of Ser70
Meroueh, S. O., Fisher, J. F., Schlegel, H. B., & Mobashery, S. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051592u · Cited by 160
The inhibition of class C β -lactamases by boronic acids
Beesley, T. J., Gascoyne, N., Knott-Hunziker, V., Petursson, S., Waley, S. G., Jaurin, B., & Grundström, T. (1983) · Biochemical Journal · doi:10.1042/bj2090229 · Cited by 159
Atomic Resolution Structures of CTX-M β-Lactamases: Extended Spectrum Activities from Increased Mobility and Decreased Stability
Chen, Y., Delmas, J., Sirot, J., Shoichet, B. K., & Bonnet, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.010 · Cited by 154
OXA-Type β-Lactamases
Naas, T., & Nordmann, P. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112185101 · Cited by 154
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
Gin, A. S., Dilay, L., Karlowsky, J. A., Walkty, A. J., Rubinstein, E., & Zhanel, G. G. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.365 · Cited by 153
Association of Antibiotic Utilization Measures and Control of Multiple-Drug Resistance inKlebsiella pneumoniae
PATTERSON, J. E., Hardin, T. C., Kelly, C. C., Carvajal-García, R., & Jorgensen, J. H. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501787 · Cited by 152
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli
Blázquez, J., Baquero, M.-R., Cantón, R., Alós, J.-I., & Baquero, F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2059 · Cited by 152
Types of beta-lactamase determined by plasmids in gram-negative bacteria
Matthew, M., Hedges, R. W., & Smith, J. T. (1979) · Journal of Bacteriology · doi:10.1128/jb.138.3.657-662.1979 · Cited by 150
Structural Basis for Clinical Longevity of Carbapenem Antibiotics in the Face of Challenge by the Common Class A β-Lactamases from the Antibiotic-Resistant Bacteria
Maveyraud, L., Mourey, L., Kotra, L. P., Pédelacq, J. D., Guillet, V., Mobashery, S., & Samama, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9818001 · Cited by 149
Mechanisms of Antibiotic Resistance: QM/MM Modeling of the Acylation Reaction of a Class A β-Lactamase with Benzylpenicillin
Hermann, J. C., Hensen, C., Ridder, L., Mulholland, A. J., & Höltje, H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044210d · Cited by 147
Crystallographic Structure of a Phosphonate Derivative of the Enterobacter cloacae P99 Cephalosporinase: Mechanistic Interpretation of a .beta.-Lactamase Transition-State Analog
Lobkovsky, E. B., Billings, E. M., Moews, P. C., Rahil, J. F., Pratt, R. F., & Knox, J. R. (1994) · Biochemistry · doi:10.1021/bi00188a004 · Cited by 144
Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents
Nikaido, H., Liu, W., & Rosenberg, E. Y. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.337 · Cited by 143
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage
Bradley, S. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.261 · Cited by 143
Structure-Based Enhancement of Boronic Acid-Based Inhibitors of AmpC β-Lactamase
Weston, G. S., Blázquez, J., Baquero, F., & Shoichet, B. K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980343w · Cited by 142
Serine protease mechanism: structure of an inhibitory complex of .alpha.-lytic protease and a tightly bound peptide boronic acid
Bone, R. F., Shenvi, A. B., Kettner, C. A., & Agard, D. A. (1987) · Biochemistry · doi:10.1021/bi00398a012 · Cited by 142
In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Penicillin‐Binding Protein‐Mediated Resistance in Pneumococci and Staphylococci
Chambers, H. F. “. (1999) · The Journal of Infectious Diseases · doi:10.1086/513854 · Cited by 140
Site-directed mutants, at position 166, of RTEM-1 beta-lactamase that form a stable acyl-enzyme intermediate with penicillin.
Adachi, H., Ohta, T., & Matsuzawa, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49972-3 · Cited by 139
Inactivation of class A .beta.-lactamases by clavulanic acid: the role of arginine-244 in a proposed nonconcerted sequence of events
Imtiaz, U., Billings, E. M., Knox, J. R., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00064a003 · Cited by 138
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases ,
Ke, W., Bethel, C. R., Thomson, J. M., Bonomo, R. A., & van den Akker, F. (2007) · Biochemistry · doi:10.1021/bi700300u · Cited by 138
Self-citation
Structure-Based Approach for Binding Site Identification on AmpC β-Lactamase
Powers, R. A., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020002p · Cited by 138
Site-directed mutagenesis of β-lactamase I. Single and double mutants of Glu-166 and Lys-73
Gibson, R. M., Christensen, H., & Waley, S. G. (1990) · Biochemical Journal · doi:10.1042/bj2720613 · Cited by 138
Pharmacokinetics of azithromycin in rats and dogs
Shepard, R. M., & Falkner, F. C. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.49 · Cited by 136
An efficient method for generating proteins with altered enzymatic properties: application to beta-lactamase.
Oliphant, A., & Struhl, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9094 · Cited by 135
A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds
Galleni, M., Amicosante, G., & Frère, J.-M. (1988) · Biochemical Journal · doi:10.1042/bj2550123 · Cited by 134
Reversible inhibitors of penicillinases
Kiener, P. A., & Waley, S. G. (1978) · Biochemical Journal · doi:10.1042/bj1690197 · Cited by 134
Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate
Bradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A., & Bush, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.761 · Cited by 133
In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
Self-citation
Mono- and Binuclear Zn2+-β-Lactamase
Soto, R. P., Bauer, R., Frère, J., Galleni, M., Meyer‐Klaucke, W., Nolting, H. F., Rossolini, G. M., de Seny, D., Hernandez-Valladares, M., Zeppezauer, M. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13242 · Cited by 132
Inhibition of a Class C β-Lactamase by a Specific Phosphonate Monoester
Pratt, R. F. (1989) · Science · doi:10.1126/science.2814513 · Cited by 131
Nanomolar Inhibitors of AmpC β-Lactamase
Morandi, F., Caselli, E., Morandi, S., Focia, P. J., Blázquez, J., Shoichet, B. K., & Prati, F. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0288338 · Cited by 130
Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiols
Liénard, B. M. R., Garau, G., Horsfall, L., Karsisiotis, A. I., Damblon, C., Lassaux, P., Papamicaël, C. A., Roberts, G. C. K., Galleni, M., Dideberg, O., et al. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b802311e · Cited by 129
Genetic and Functional Analysis of the Chromosome-Encoded Carbapenem-Hydrolyzing Oxacillinase OXA-40 ofAcinetobacter baumannii
Héritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Antibacterial Activity of Imipenem: The First Thienamycin Antibiotic
Kropp, H., Gerckens, L. S., Sundelof, J. G., & Kahan, F. M. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.supplement_3.s389 · Cited by 128
Insights into Class D β-Lactamases Are Revealed by the Crystal Structure of the OXA10 Enzyme from Pseudomonas aeruginosa
Maveyraud, L., Golemi, D., Kotra, L. P., Tranier, S., Vakulenko, S. B., Mobashery, S., & Samama, J. (2000) · Structure · doi:10.1016/s0969-2126(00)00534-7 · Cited by 127
Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria
Bush, K., Freudenberger, J. S., & SYKES, R. B. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.3.414 · Cited by 126
Prospects for the next anti-Pseudomonas drug
Page, M. G. P., & Heim, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.006 · Cited by 125
Ultrahigh Resolution Structure of a Class A β-Lactamase: On the Mechanism and Specificity of the Extended-spectrum SHV-2 Enzyme
Nukaga, M., Mayama, K., Hujer, A. M., Bonomo, R. A., & Knox, J. R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00210-9 · Cited by 123
Self-citation
Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)
Belaaouaj, A., Lapouméroulie, C., CaniÃ§a, M. M., Vedel, G., Névot, P., Krishnamoorthy, R., & Paul, G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07010.x · Cited by 123
Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives
Payne, D. J., Bateson, J. H., Gasson, B. C., Proctor, D. G., Khushi, T., Farmer, T. H., Tolson, D., Bell, D., Skett, P. W., MARSHALL, A. C., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.135 · Cited by 123
Crystal Structure of 6α-(Hydroxymethyl)penicillanate Complexed to the TEM-1 β-Lactamase from Escherichia coli : Evidence on the Mechanism of Action of a Novel Inhibitor Designed by a Computer-Aided Process
Maveyraud, L., Massova, I., Birck, C., Miyashita, K., Samama, J., & Mobashery, S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9609718 · Cited by 122
Structure of the SHV-1 β-Lactamase
Kuzin, A. P., Nukaga, M., Nukaga, Y., Hujer, A. M., Bonomo, R. A., & Knox, J. R. (1999) · Biochemistry · doi:10.1021/bi990136d · Cited by 121
Self-citation
Structure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase
Powers, R. A., Morandi, F., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00799-2 · Cited by 121
Structural and kinetic characterization of a β-lactamase-inhibitor protein
Strynadka, N. C. J., Jensen, S. E., Johns, K. L., Blanchard, H., Page, M. G. P., Matagne, A., Frère, J., & James, M. N. G. (1994) · Nature · doi:10.1038/368657a0 · Cited by 120
Structure, Function, and Inhibition along the Reaction Coordinate of CTX-M β-Lactamases
Chen, Y., Shoichet, B. K., & Bonnet, R. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042850a · Cited by 120
Allergic Bronchopulmonary Mycosis Caused by the Basidiomycetous Fungus Schizophyllum commune
Kamei, K., Unno, H., Nagao, K., Kuriyama, T., Nishimura, K., & Miyaji, M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.305 · Cited by 120
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem
Levin, A. S. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00415.x · Cited by 120
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
Livermore, D. M., Mushtaq, S., Warner, M., Miossec, C., & Woodford, N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn320 · Cited by 120
Sulbactam/Ampicillin
Campoli-Richards, D. M., & Brogden, R. N. (1987) · Drugs · doi:10.2165/00003495-198733060-00003 · Cited by 119
Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations
Buynak, J. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.012 · Cited by 118
Thiomandelic Acid, a Broad Spectrum Inhibitor of Zinc β-Lactamases
Mollard, C., Moali, C., Papamicaël, C. A., Damblon, C., Vessilier, S., Amicosante, G., Schofield, C. J., Galleni, M., Frère, J., & Roberts, G. C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107054200 · Cited by 118
Three-Dimensional Structure of AmpC β-Lactamase from Escherichia c oli Bound to a Transition-State Analogue: Possible Implications for the Oxyanion Hypothesis and for Inhibitor Design
Usher, K. C., Blaszczak, L. C., Weston, G. S., Shoichet, B. K., & Remington, S. J. (1998) · Biochemistry · doi:10.1021/bi981210f · Cited by 117
The bactericidal action of penicillin: new clues to an unsolved mystery
Bayles, K. W. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01762-5 · Cited by 116
Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation
Lodise, T. P., Lomaestro, B. M., Rodvold, K. A., Danziger, L. H., & Drusano, G. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4718-4724.2004 · Cited by 116
IRT and CMT β-lactamases and inhibitor resistance
Cantón, R., Morosini, M.-I., Martin, O., de la Maza, S., & de la Pedrosa, E. G. G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01849.x · Cited by 115
Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors
Videl, G., Belaaouaj, A., Gilly, L., Labia, R., Philippon, A., Névot, P., & Paul, G. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.4.449 · Cited by 115
Structures of Ceftazidime and Its Transition-State Analogue in Complex with AmpC β-Lactamase: Implications for Resistance Mutations and Inhibitor Design,
Powers, R. A., Caselli, E., Focia, P. J., Prati, F., & Shoichet, B. K. (2001) · Biochemistry · doi:10.1021/bi0109358 · Cited by 115
Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli
Henquell, C., Chanal, C., Sirot, D., Labia, R., & Sirot, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.427 · Cited by 115
Elucidation of the role of arginine-224 in the turnover processes of class A .beta.-lactamases
Zafaralla, G. C., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1992) · Biochemistry · doi:10.1021/bi00130a016 · Cited by 114
Emergence of imipenem resistance in clinical Escherichia coli during therapy
Oteo, J., Delgado‐Iribarren, A., Vega, D., Bautista, V., Rodríguez, M. C., Velasco, M., Saavedra, J. M., Pérez-Vázquez, M. D., García-Cobos, S., Martı́nez-Martı́nez, L., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.012 · Cited by 112
N-Arylsulfonyl Hydrazones as Inhibitors of IMP-1 Metallo-β-Lactamase
Siemann, S., Evanoff, D. P., Marrone, L., Clarke, A. J., Viswanatha, T., & Dmitrienko, G. I. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2450-2457.2002 · Cited by 112
Role of the conserved amino acids of the ‘SDN’ loop (Ser130, Asp131 and Asn132) in a class A β-lactamase studied by site-directed mutagenesis
Jacob, F., Joris, B., Lepage, S., Dusart, J., & Frère, J. (1990) · Biochemical Journal · doi:10.1042/bj2710399 · Cited by 112
Inactivation of the RTEM .beta.-lactamase from Escherichia coli. Interaction of penam sulfones with the enzyme
Fisher, J. F., Charnas, R. L., Bradley, S. M., & Knowles, J. R. (1981) · Biochemistry · doi:10.1021/bi00513a004 · Cited by 111
Inhibition of TEM-2 β-Lactamase from Escherichia coli by Clavulanic Acid: Observation of Intermediates by Electrospray Ionization Mass Spectrometry,
Brown, R. P. A., Aplin, R. T., & Schofield, C. J. (1996) · Biochemistry · doi:10.1021/bi961044g · Cited by 111
Molecular basis of beta-lactamase induction in bacteria
Bennett, P. M., & Chopra, I. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.153 · Cited by 111
A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate
Sirot, D., Recule, C., Chaibi, E. B., Bret, L., Croizé, J., Chanal, C., Labia, R., & Sirot, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1322 · Cited by 110
Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic Support
Poirel, L., & Nordmann, P. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378427 · Cited by 110
Identification of a Series of Tricyclic Natural Products as Potent Broad-Spectrum Inhibitors of Metallo-β-Lactamases
Payne, D. J., Hueso-Rodríguez, J. A., Boyd, H., Concha, N. O., Janson, C. A., Gilpin, M. L., Bateson, J. H., Cheever, C. A., Niconovich, N. L., Pearson, S. C., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1880-1886.2002 · Cited by 109
Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene
Doran, J. L., Leskiw, B. K., Aippersbach, S. E., & Jensen, S. E. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.9.4909-4918.1990 · Cited by 108
Acyl-intermediate Structures of the Extended-spectrum Class A β-Lactamase, Toho-1, in Complex with Cefotaxime, Cephalothin, and Benzylpenicillin
Shimamura, T., Shimizu‐Ibuka, A., Fushinobu, S., Wakagi, T., Ishiguro, M., Ishii, Y., & Matsuzawa, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207884200 · Cited by 107
Genetic and Molecular Characterization of β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae with Unusually High Resistance to Ampicillin
Kaczmarek, F. S., Gootz, T. D., Dib-Hajj, F. B., Shang, W., Hallowell, S., & Cronan, M. T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1630-1639.2004 · Cited by 106
Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6.alpha.- and 6.beta.-monodeuterio and of 6,6-dideuterio derivatives with RTEM .beta.-lactamase from Escherichia coli. Crystal structure of penicillanic acid sulfone
Brenner, D. G., Knowles, J. R., & Rihs, G. (1981) · Biochemistry · doi:10.1021/bi00516a003 · Cited by 106
Inhibition of β-lactamase by clavulanate
Chen, C. C. H., & Herzberg, O. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90472-v · Cited by 105
Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection
Retsema, J. A., English, A. R., Girard, A., Lynch, J. E., ANDERSON, M. R., Brennan, L. A., Cimochowski, C. R., FAIELLA, J. A., Norcia, W., & Sawyer, P. S. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_5.s528 · Cited by 105
β -lactamase inhibitors. The inhibition of serine β -lactamases by specific boronic acids
Crompton, I. E., Cuthbert, B. K., Lowe, G. M., & Waley, S. G. (1988) · Biochemical Journal · doi:10.1042/bj2510453 · Cited by 105
Comparison of β‐lactamases of classes A and D: 1.5‐Å crystallographic structure of the class D OXA‐1 oxacillinase
Sun, T., Nukaga, M., Mayama, K., Braswell, E. H., & Knox, J. R. (2003) · Protein Science · doi:10.1110/ps.0224303 · Cited by 102

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T., & Cheng, Z. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,520
Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
Breijyeh, Z., Jubeh, B., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25061340 · Cited by 1,582
Synthesis of Heterocycles via Palladium-Catalyzed Carbonylations
Wu, X., Neumann, H., & Beller, M. (2012) · Chemical Reviews · doi:10.1021/cr300100s · Cited by 1,286
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
TZOUVELEKIS, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,190

See all 1,709

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks